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Abstract
A total synthesis of brevetoxin A is reported. Two tetracyclic coupling partners, prepared from
previously reported advanced fragments, were effectively united via a Horner—Wittig olefination.
The resulting octacycle was progressed to substrates that were explored for reductive etherification,
the success of which led to a penultimate tetraol intermediate. The tetraol was converted to the natural
product through an expeditious selective oxidative process, followed by methylenation.
The exquisite structures of marine polycyclic ether natural products have captured the
imagination of synthetic chemists for over two decades. The structures of the polyether ladder
toxins characteristically contain a linear series of trans fused ether rings of varying sizes from
five to nine members with assorted methyl and hydroxyl substituents appended. As novel
technologies for the convergent preparation of these targets have emerged, a number of total
syntheses of the ladder toxins have been completed.1 The structure of brevetoxin A (1), a
representative member of this class, was first elucidated in 1986 by Shimizu2a,b, and co-
workers by X-ray analysis and independently determined by Nakanishi through spectroscopic
studies.2c Brevetoxin A (1) contains ten rings (including five-, six-, seven-, eight, and nine-
membered oxacycles) fused in a linear array adorned by 22 tetrahedral stereocenters. A
metabolite of Karenia brevis, brevetoxin A is a toxic component of the infamous red tide
phenomenon, which has been responsible for massive fish kills as well as neurotoxic shellfish
poisoning and bronchial irritation in humans.3 The potent activity of brevetoxin A is attributed
to strong binding to the α subunit of the voltage-sensitive sodium ion channels effecting an
increase in the mean channel open time and inhibiting channel inactivation.3a To date, the
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landmark total synthesis reported by Nicolaou stands as the only completed synthesis of this
intriguing target.4
The planned approach for the total synthesis of brevetoxin A5 focused on a versatile endgame
that would exploit the selective manipulation of tetraol 2 (Scheme 1), which would derive from
mixed methyl ketal 3 via stereoselective reductive etherification. Ketal 3 would be obtained
through the stereoselective Horner—Wittig coupling6 of phosphine oxide 5 and aldehyde 6.
This route was attractive not only because it allowed for optimal convergence by simplifying
the natural product into two halves of similar complexity, but also because it found precedent
in the strategy previously reported by Nicolaou.4 Further, it was reasoned that the dithioketal
moiety of aldehyde 6 could serve as a stabilized precursor to mixed ketal 3, or lead to sulfone
4 in the event that formation or reductive etherification of mixed ketal 3 proved problematic.
The Horner—Wittig coupling partners 5 and 6 would be obtained from advanced fragments
7 and 8, respectively. The BCDE fragment 7 and GHIJ subunit 8 had been previously prepared
in significant quantities through similar highly convergent [X+2+X] strategies based on a
Horner—Wadsworth—Emmons coupling of the B and E ring units (and the G and J subunits)
and subsequent construction of the central CD and HI rings.5a,b
The conversion of diol 7 to phosphine oxide 5 (Scheme 2) commenced with protection of diol
7 as the bis-p-methoxybenzyl ether and subsequent reductive cleavage of the benzyl ethers
with LiDBB to form diol 9.7 Diol 9 was protected as the bis-TBS ether, whereupon selective
cleavage of the primary TBS ether with HF·pyr afforded alcohol 10. Alcohol 10 was smoothly
transformed to phosphine oxide 11 via a sequence which involved mesylation of the alcohol,
nucleophilic displacement of the mesylate to provide the alkyl diphenylphosphine, and finally,
oxidative workup of the phosphine with H2O2.4,6 Cleavage of the TBS ether with n-Bu4NF
and formation of the methoxypropyl (MOP) acetal delivered the required phosphine oxide 5
in high yield.8
For aldehyde 6, GHIJ tetracycle 8 was treated with n-Bu4NF to cleave the TIPS ether, and the
resultant secondary alcohol was oxidized to ketone 12 with Dess-Martin periodinane (Scheme
3).9 Treatment of ketone 12 with Zn(OTf)2 and EtSH produced the dithioketal,10 and reductive
cleavage of the pivaloate ester with LiAlH4 delivered alcohol 13. While a host of conditions
proved unsuitable for the subsequent oxidation of the primary alcohol to aldehyde 6, due to
undesired oxidation of the dithioketal, the use of stoichiometric n-Pr4NRuO4 reproducibly
provided the desired aldehyde with minimal byproducts.11
With both phosphine oxide 5 and aldehyde 6 in hand, their assembly under Horner—Wittig
conditions was explored (Scheme 4).6 After some experimentation, addition of 3 equiv of LDA
to a solution of phosphine oxide 5 and aldehyde 6 at -78 °C was found to produce 63% of the
Horner—Wittig adduct. It is worthy of note that no epimerization of aldehyde 6 was observed,
despite the presence of superstoichiometric base. Exposure of the intermediate hydroxy-
phosphine oxide to KHMDS provided the desired Z-olefin 14 in 74% yield.
Having effectively coupled the BCDE and GHIJ fragments, we wished to examine the mixed
methyl ketal 3 as a precursor to the targeted nonacycle 16 (Scheme 4). Despite the dearth of
literature examples for the conversion of 7-hydroxy ketones or ketals to eight-membered cyclic
ketals, we believed that the formation of mixed ketal 3 would be possible due to the structural
pre-organization present in olefin 14. In particular, the newly-formed Z-olefin, along with the
cyclic conformational constraints about the C21—C22 and C26—C27 bonds, would be
expected to assist in the required cyclization event. Additionally, based upon the reported use
of (F3CCO2)2IPh in alcoholic solvent to convert dithioketals to dialkyl ketals,12 we reasoned
that exposure of olefin 14 to the hypervalent iodine reagent in MeOH would lead to the dimethyl
ketal 15, or to mixed ketal 3 directly. In the event, treatment of thioketal 14 with
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(F3CCO2)2IPh in MeOH rapidly removed the MOP protecting group, and led to a mixture of
the expected ketal products in a 4:1 ratio favoring the dimethyl ketal 15.13 Exposure of the
unpurified mixture to PPTS and trimethyl orthoformate in toluene provided an 80% overall
yield of cyclic mixed methyl ketal 3.
Drawing upon previous successes in our laboratory involving the reductive etherification of
precursors to the BCDE and GHIJ fragments,5a,b it was anticipated that treatment of ketal 3
with an appropriate Lewis acid in the presence of a trialkylsilane would deliver the expected
nonacycle 16 (Scheme 4). Despite extensive screening of Lewis acids (BF3·OEt2, TiCl4,
TMSOTf), solvents, silanes (Et3SiH, Me2PhSiH), and drying agents (4 Å MS, BaO), only
traces of the desired reduction product 16 were obtained. Instead, hydrolysis of the ketal, via
interception of the oxocarbenium ion by adventitious water, cleavage of the oxocene
(producing the C27 methyl ether), and intractable decomposition were repeatedly observed.
The use of i-Bu2AlH as the reducing agent also failed to bring about the intended reduction.
Borrowing from precedent in the Nicolaou synthesis, attention was turned to the reductive
etherification of sulfone 4 rather than the ketal 3 in an attempt to increase the lability of the
leaving group at C27.4,14 Removal of the MOP acetal from olefin 14 (Scheme 5) under acidic
conditions followed by treatment of the hydroxy-dithioketal with AgClO4 provided the cyclic
mixed S,O-ketal 18. Upon obtaining sulfone 4 via oxidation with m-CPBA, reductive
etherification with concomitant removal of the PMB protecting groups was readily
accomplished, furnishing diol 16 in 85% yield.
Initial attempts to complete the synthesis of brevetoxin A from diol 16 focused on the formation
of the A ring lactone followed by removal of the J ring benzyl ethers and functionalization of
the J ring side chain. While the A ring lactone could be readily constructed by treatment of diol
16 with n-Pr4NRuO4, subsequent attempts to cleave the J ring benzyl ethers under a host of
reductive or Lewis acidic conditions met with failure due to significant amounts of
decomposition. Ultimately, a strategy involving the selective oxidation of tetraol 2 was
examined. Unlike the A ring lactone derived from diol 16, the J ring benzyl ethers could be
readily cleaved from diol16 itself to deliver tetraol 2. Thus, brevetoxin A (1) was accessed in
three straightforward operations from diol 16 (Scheme 5). Reductive cleavage of the J ring
benzyl ethers, and subsequent exposure of tetraol 2 to PhI(OAc)2 in the presence of catalytic
TEMPO15 served to selectively form the A-ring lactone and the C44 aldehyde while leaving
the axially-disposed C39 secondary alcohol unaffected. The unpurified decacyclic aldehyde
17 was treated with Eschenmoser′s salt in the presence of Et3N4,16 to complete the synthesis
of brevetoxin A (1). Synthetic brevetoxin A (1) was identical in all respects (1H and 13C NMR,
IR, HRMS, [α]D) to an authentic sample.4,17
In summary, the total synthesis of brevetoxin A was completed from aldehyde 6 and phosphine
oxide 5 through a stereoselective Horner—Wittig olefination to assemble two advanced
tetracycles. The uncommon cyclization of a medium ring mixed methyl ketal was
accomplished and the mixed methyl ketal was assessed as a substrate for a reductive
etherification of an oxocene. Ultimately, a sulfone-based approach proved superior and set the
stage for a selective oxidation strategy of tetraol 2, allowing the completion of the second total
synthesis of brevetoxin A (1).
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Refer to Web version on PubMed Central for supplementary material.
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Retrosynthetic Analysis of Brevetoxin A
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Formation of Phosphine Oxide 5a
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Preparation of Aldehyde 6
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Coupling of Tetracyclic Fragments 5 and 6
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Completion of Brevetoxin A (1)a
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